RecruitingNCT05918510
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Studying Squamous cell carcinoma of the oropharynx
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Regina Elena Cancer Institute
- Intervention
- Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx(diagnostic_test)
- Enrollment
- 142 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2029
Study locations (1)
- "Regina Elena" National Cancer Institute, Rome, Italy
Collaborators
Istituto Clinico Humanitas · Istituto Europeo di Oncologia · Azienda Policlinico Umberto I · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · University of Firenze and Siena, Napoli, Italy · Weizmann Institute of Science
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05918510 on ClinicalTrials.govOther trials for Squamous cell carcinoma of the oropharynx
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06915038ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the OropharynxIndiana University
- RECRUITINGPHASE1NCT06747390Intratumoral Lidocaine Injection Before Oropharyngeal Cancer SurgeryRyan Carey
- RECRUITINGPHASE2NCT06702033The Minimalist Trial-2Washington University School of Medicine
- RECRUITINGPHASE1NCT06589609Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal CancerBlueSky Immunotherapies GmbH
- RECRUITINGPHASE2NCT06223568Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) CancerNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT05582122SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal CancersUNICANCER
- ACTIVE NOT RECRUITINGNCT06592716Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Rigshospitalet, Denmark
- RECRUITINGPHASE2NCT06323460Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal CancerOhio State University Comprehensive Cancer Center
See all trials for Squamous cell carcinoma of the oropharynx →